Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathologic and Prognostic Significance of CD24 in Gallbladder Carcinoma

  • Published:
Pathology & Oncology Research

Abstract

CD24, a small cell surface protein, has emerged as a novel oncogene and prognostic factor for poor outcomes in many human cancers. However, the association of CD24 expression pattern in gallbladder carcinoma with patients’ survival has not been reported. To shed light on this problem, we performed an analysis on the relationship between CD24 expression and prognostic parameters in gallbladder carcinoma. CD24 expression was examined immunohistochemically on paraffin-embedded tissue specimens from 207 patients who underwent surgical treatment for gallbladder carcinoma in the period between January 2004 and May 2009. CD24 positive expression was found in 78.7% (163/207) of the tumor samples. It tended to be associated positively with tumor histological grades and pT stages. Kaplan-Meier curves showed that CD24 positive expression was significantly related to decreased overall survival (p < 0.01). Multivariate analysis, including CD24 expression, pT stage, tumor grade, and resection margin involvement, showed that CD24 positive expression was an independent prognostic marker in gallbladder carcinoma (p = 0.02; relative risk = 1.6). Our data demonstrate for the first time that CD24 is an important marker of malignancy and poor prognosis in gallbladder carcinoma. Its detection combined with cancerous staging may increase the ability of investigators to predict the prognosis of patients with gallbladder carcinoma. Furthermore, the CD24 antigen represents an attractive target for specific therapies with monoclonal antibodies in patients with CD24-overexpressing gallbladder carcinoma, so the detection of CD24 may help clinicians select patients likely to benefit from novel molecular therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roa I, De Aretxabala X, Araya JC et al (2006) Preneoplastic lesions in gallbladder cancer. J Surg Oncol 93:615–623

    Article  PubMed  Google Scholar 

  2. Lewis JT, Talwalkar JA, Rosen CB et al (2003) Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasiacarcinoma sequence. Am J Surg Pathol 31:907–913

    Google Scholar 

  3. Misra S, Chaturvedi A, Misra NC et al (2003) Carcinoma of the gallbladder. Lancet Oncol 4:167–176

    Article  PubMed  Google Scholar 

  4. Taguchi T, Kiyokawa N, Mimori K et al (2003) Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol 170:252–260

    PubMed  CAS  Google Scholar 

  5. Jung KC, Park WS, Kim HJ et al (2004) TCR independent and caspase-independent apoptosis of murine thymocytes by CD24 cross-linking. J Immunol 172:795–802

    PubMed  CAS  Google Scholar 

  6. Kristiansen G, Sammar M, Altevogt P (2004) Tumor biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35:255–262

    Article  PubMed  CAS  Google Scholar 

  7. Friederichs J, Zeller Y, Hafezi-Moghadam A et al (2000) The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60:6714–6722

    PubMed  CAS  Google Scholar 

  8. Schindelmann S, Windisch J, Grundmann R et al (2002) Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumor Biol 23:139–145

    Article  CAS  Google Scholar 

  9. Senner V, Sturm A, Baur I et al (1999) CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 58:795–802

    Article  PubMed  CAS  Google Scholar 

  10. Kristiansen G, Schluns K, Yonwei Y et al (2003) CD24 is an independent prognostic marker of survival in non-small cell lung cancer patients. Br J Cancer 88:231–235

    Article  PubMed  CAS  Google Scholar 

  11. Kristiansen G, Winzer KJ, Mayordomo E et al (2003) CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9:4906–4913

    PubMed  CAS  Google Scholar 

  12. Kristiansen G, Pilarsky C, Pervan J et al (2004) CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58:183–192

    Article  PubMed  Google Scholar 

  13. Su MC, Hsu C, Kao HL et al (2006) CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 235:34–39

    Article  PubMed  CAS  Google Scholar 

  14. Weichert W, Denkert C, Burkhardt M et al (2005) Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11:6574–6581

    Article  PubMed  CAS  Google Scholar 

  15. Kristiansen G, Denkert C, Karsten S et al (2002) CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol 161:1215–1221

    Article  PubMed  CAS  Google Scholar 

  16. Winkler A, Zigeuner R, Rehak P et al (2007) CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 450:59–64

    Article  PubMed  CAS  Google Scholar 

  17. Fan YZ, Zhang JT, Yang HC et al (2002) Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance. World J Gastroenterol 8:1138–1143

    PubMed  CAS  Google Scholar 

  18. Taner CB, Nagorney DM, Donohue JH (2004) Surgical treatment of gallbladder cancer. J Gastrointest Surg 8:83–89

    Article  PubMed  Google Scholar 

  19. Ma HB, Hu HT, Di ZL et al (2005) Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol 11:744–747

    PubMed  Google Scholar 

  20. Aigner S, Ramos CL, Hafezi-Moghadam A et al (1998) CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12:1241–1251

    PubMed  CAS  Google Scholar 

  21. Lim SC (2005) CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother 59:351–354

    Article  Google Scholar 

  22. Zhang Y, Yao F, Yao X et al (2009) Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24-phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 21:1113–1121

    PubMed  CAS  Google Scholar 

  23. Welsh JB, Zarrinkar PP, Sapinoso LM et al (2001) Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 98:1176–1181

    Article  PubMed  CAS  Google Scholar 

  24. Sagiv E, Memeo L, Karin A et al (2006) CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology 131:630–639

    Article  PubMed  CAS  Google Scholar 

  25. Sagiv E, Arber N (2008) The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy. Exp Rev Gastroenterol Hepatol 2:125–1233

    Article  CAS  Google Scholar 

  26. Huang LR, Hsu HC (1995) Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 55:4717–4721

    PubMed  CAS  Google Scholar 

  27. Lee JH, Kim SH, Lee ES et al (2009) CD24 overexpression in cancer development and progression: a meta-analysis. Oncol Rep 22:1149–1156

    PubMed  CAS  Google Scholar 

  28. Jacob J, Bellach J, Grutzmann R et al (2004) Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 4:454–460

    Article  PubMed  CAS  Google Scholar 

  29. Park JS, Jung WH, Kim JK et al (2009) Estrogen receptor α, estrogen receptor β, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma. J Surg Res 152:104–110

    Article  PubMed  CAS  Google Scholar 

  30. Varga M, Obrist P, Schneeberger S et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, 410011, People’s Republic of China

    Bo Liu, Jiarui Jiang & Xiongying Miao

  2. Hepatobiliary and Enteric Surgery Research Center, Central South University, Changsha, Hunan Province, 410008, People’s Republic of China

    Bo Liu, Yangde Zhang, Mingmei Liao, Zhansheng Deng & Liansheng Gong

  3. Department of Orthopedics, The First Xiangya Hospital, Central South University, Changsha, Hunan Province, 410011, People’s Republic of China

    Zhansheng Deng & Kai Wu

  4. Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan Province, 410011, People’s Republic of China

    Ling Lynn

Authors
  1. Bo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yangde Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mingmei Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhansheng Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Liansheng Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiarui Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ling Lynn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kai Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiongying Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiongying Miao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, B., Zhang, Y., Liao, M. et al. Clinicopathologic and Prognostic Significance of CD24 in Gallbladder Carcinoma. Pathol. Oncol. Res. 17, 45–50 (2011). https://doi.org/10.1007/s12253-010-9278-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-010-9278-2

Keywords

Search

Navigation